To be able to make drugs from its gene data, one biotech bought a company founded by Nobel Prize winner K. Barry Sharpless.

FORBES: Biotech Topples The Ivory Tower

From the late 1960s onward, William Knowles, Ryoji Noyori, Barry Sharpless and Henri Kagan, among others, began to develop catalysts that made great quantities of single enantiomers very fast.

ECONOMIST: MONITOR

For instance, K. Barry Sharpless , who shares this year's chemistry prize, founded a company called Coelecanth , which was bought by Lexicon Genetics (nasdaq: LEXG - news - people) in July.

FORBES: Magazine Article